You are about to leave the current site. Are you sure you want to continue?
news
Global Cross-Company Audit Initiative Launched
We are delighted to announce the launch of our global cross-company audit initiative, a key step toward harmonizing practices across the KD Pharma Group.
TOP TWO PLACES IN THE AOCS LABORATORY PROFICIENCY PROGRAMME!
Our QC teams in Bexbach, Germany and in Mulgrave, Canada, achieved first and second place in the AOCS Laboratory Proficiency Program for GOED Nutraceutical Oils.
KD Pharma Group announces acquisition of dsm-firmenich’s marine lipids business
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites in Canada and Peru
Groundbreaking collaboration between KD Pharma Group and DUDE CHEM
We are delighted to announce the collaboration between KD Pharma Group and DUDE CHEM, a fast growing deeptech company specialized in green chemistry manufacturing, for an impactful digitalization pilot project.
First place in the AOCS Laboratory Proficiency Program!
We are very proud to announce that our Quality Control team in KD Pharma Bexbach, Germany, has achieved the first place in the AOCS Laboratory Proficiency Program for GOED Nutraceutical Oils!
60% reduction of carbon emissions at our production sites in Germany
Environmental impact and sustainability have always played an important role in the KD Pharma Group's approach to business. Minimizing waste and improving overall efficiency are cornerstones of the organization.
We are pleased to announce the opening of our new R&D laboratory and offices at our world-class synthesis and fractionation facility in Seal Sands, UK.
KD Pharma VP of sales, Uwe Westeppe, was interviewed at DCAT week
KD Pharma is a very dynamic, fast-growing company, that is constantly enlarging its technology toolbox for chemical transformations, purification and separation, and encapsulation under cGMP.